439 related articles for article (PubMed ID: 17558306)
21. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK
Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654
[TBL] [Abstract][Full Text] [Related]
22. Expression and adaptive regulation of amino acid transport system A in a placental cell line under amino acid restriction.
Jones HN; Ashworth CJ; Page KR; McArdle HJ
Reproduction; 2006 May; 131(5):951-60. PubMed ID: 16672359
[TBL] [Abstract][Full Text] [Related]
23. High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats.
Pinho MJ; Serrão MP; Soares-da-Silva P
Am J Physiol Renal Physiol; 2007 May; 292(5):F1452-63. PubMed ID: 17264310
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
25. Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells.
Kaneko S; Ando A; Okuda-Ashitaka E; Maeda M; Furuta K; Suzuki M; Matsumura M; Ito S
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):464-71. PubMed ID: 17197568
[TBL] [Abstract][Full Text] [Related]
26. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine.
Atluri H; Talluri RS; Mitra AK
Int J Pharm; 2008 Jan; 347(1-2):23-30. PubMed ID: 17686592
[TBL] [Abstract][Full Text] [Related]
27. Interactions of y+LAT1 and 4F2hc in the y+l amino acid transporter complex: consequences of lysinuric protein intolerance-causing mutations.
Toivonen M; Tringham M; Kurko J; Terho P; Simell O; Heiskanen KM; Mykkänen J
Gen Physiol Biophys; 2013 Dec; 32(4):479-88. PubMed ID: 23940088
[TBL] [Abstract][Full Text] [Related]
28. L-leucine transport in human breast cancer cells (MCF-7 and MDA-MB-231): kinetics, regulation by estrogen and molecular identity of the transporter.
Shennan DB; Thomson J; Gow IF; Travers MT; Barber MC
Biochim Biophys Acta; 2004 Aug; 1664(2):206-16. PubMed ID: 15328053
[TBL] [Abstract][Full Text] [Related]
29. Identification and functional characterization of a Na(+)-independent large neutral amino acid transporter (LAT2) on ARPE-19 cells.
Gandhi MD; Pal D; Mitra AK
Int J Pharm; 2004 May; 275(1-2):189-200. PubMed ID: 15081149
[TBL] [Abstract][Full Text] [Related]
30. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
[TBL] [Abstract][Full Text] [Related]
31. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
32. Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions.
Kim DK; Ahn SG; Park JC; Kanai Y; Endou H; Yoon JH
Anticancer Res; 2004; 24(3a):1671-5. PubMed ID: 15274339
[TBL] [Abstract][Full Text] [Related]
33. Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols.
Li S; Whorton AR
J Biol Chem; 2005 May; 280(20):20102-10. PubMed ID: 15769744
[TBL] [Abstract][Full Text] [Related]
34. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
[TBL] [Abstract][Full Text] [Related]
35. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
[TBL] [Abstract][Full Text] [Related]
36. Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2-4F2hc exchanger.
Ramadan T; Camargo SM; Herzog B; Bordin M; Pos KM; Verrey F
Pflugers Arch; 2007 Jun; 454(3):507-16. PubMed ID: 17273864
[TBL] [Abstract][Full Text] [Related]
37. Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells.
Yoon JH; Kim IJ; Kim H; Kim HJ; Jeong MJ; Ahn SG; Kim SA; Lee CH; Choi BK; Kim JK; Jung KY; Lee S; Kanai Y; Endou H; Kim DK
Cancer Lett; 2005 May; 222(2):237-45. PubMed ID: 15863273
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Müller cells.
Umapathy NS; Li W; Mysona BA; Smith SB; Ganapathy V
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3980-7. PubMed ID: 16249471
[TBL] [Abstract][Full Text] [Related]
39. Mutation of the 4F2 heavy-chain carboxy terminus causes y+ LAT2 light-chain dysfunction.
Chubb S; Kingsland AL; Bröer A; Bröer S
Mol Membr Biol; 2006; 23(3):255-67. PubMed ID: 16785209
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2.
Takabe W; Kanai Y; Chairoungdua A; Shibata N; Toi S; Kobayashi M; Kodama T; Noguchi N
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1640-5. PubMed ID: 15178563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
